UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter to the Editor “Gender related aspects of bleeding with rivaroxaban in venous thromboembolism — Potential for pitfalls”

Thrombosis research, 2016-12, Vol.148, p.152-153

Beyer-Westendorf, Jan, MD

2016

Volltextzugriff (PDF)

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients

Thrombosis research, 2016-12, Vol.148, p.59-62

2016

Volltextzugriff (PDF)

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE

Chest, 2016-11, Vol.150 (5), p.1059-1068

2016

Volltextzugriff (PDF)

Thromboembolische Komplikationen bei COVID-19

Deutsche medizinische Wochenschrift, 2020-12, Vol.145 (24), p.1728-1734

2020

Volltextzugriff (PDF)

Blutungskomplikationen unter oraler Antikoagulation

Deutsche medizinische Wochenschrift, 2015-02, Vol.140 (3), p.214-215

Beyer-Westendorf, Jan

2015

Volltextzugriff (PDF)

Neue orale Antikoagulanzien und Endoskopie – was ist zu beachten?

Deutsche medizinische Wochenschrift, 2015-08, Vol.140 (16), p.1227-1230

2015

Volltextzugriff (PDF)

Blutgerinnung und hormonelle Kontrazeptiva: Was muss man bei der Verordnung beachten?

Gynäkologische Endokrinologie, 2022-10, Vol.20 (4), p.263-271

2022

Volltextzugriff (PDF)

Abstract 18238: Transition from Vitamin-K-antagonists to New Oral Anticoagulants in Daily Care - First Results of the Prospective NOAC Registry (NCT 01588119)

Circulation (New York, N.Y.), 2012-11, Vol.126 (suppl_21)

2012

Volltextzugriff (PDF)

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

International journal of cardiology, 2018-02, Vol.253, p.71-77

2018

Volltextzugriff (PDF)

A REAL-WORD, PROSPECTIVE OBSERVATIONAL STUDY TO COMPARE RIVAROXABAN VERSUS VITAMIN K ANTAGONIST TREATMENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.201

2022

Volltextzugriff (PDF)

Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

Stroke (1970), 2022-02, Vol.53 (2), p.532-543

2022

Volltextzugriff (PDF)

579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S332-S333

2019

Volltextzugriff (PDF)

Abstract 13927: Advanced Age and Preferential Use of Vitamin K Antagonists in Severe Renal Impairment: First Results of the XARENO Registry in Patients With Non-valvular Atrial Fibrillation and Non-dialysis Dependent Advanced Chronic Kidney Disease

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13927-A13927

2020

Volltextzugriff (PDF)

ANDEXANET ALFA FOR ACUTE BLEEDING DURING TREATMENT WITH ENOXAPARIN

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1856-1856

2021

Volltextzugriff (PDF)

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses

Thrombosis research, 2016-08, Vol.144, p.62-68

2016

Volltextzugriff (PDF)

59: ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY

Critical care medicine, 2019-01, Vol.47 (1), p.30-30

2019

Volltextzugriff (PDF)

Abstract T MP57: Are The Recommendations For The Emergency Management Of Acute Ischemic Stroke Patients On Novel Oral Anticoagulants Sufficient?

Stroke (1970), 2014-02, Vol.45 (suppl_1)

2014

Volltextzugriff (PDF)

The CHA 2 DS 2 -VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

International journal of cardiology, 2018-02, Vol.253, p.71

2018

Volltextzugriff (PDF)

Stroke prevention in atrial fibrillation: evidence from real-life studies: Table 1

European heart journal supplements, 2015-07, Vol.17 (suppl D), p.D42-D52

2015

Volltextzugriff (PDF)

Continued commitment to safety: building on the existing rivaroxaban knowledge base: Table 1

European heart journal supplements, 2015-07, Vol.17 (suppl D), p.D21-D28

2015

Volltextzugriff (PDF)

Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Abstract 13021: Comparative Risk of Major Bleeding With Rivaroxaban and Warfarin: Population Based Cohort Study of Unprovoked Venous Thromboembolism

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A13021-A13021

2018

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(23)

Sprache

Englisch
(18)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Female
(3)
Hematology, Oncology And Palliative Medicine
(3)
Humans
(3)
Aged
(2)
Klinischer Fortschritt
(2)
Male
(2)
Prospective Studies
(2)
Rivaroxaban
(2)
Treatment Outcome
(2)
Venous Thromboembolism
(2)
Adult
(1)
Aged, 80 And Over
(1)
Algorithms
(1)
Anticoagulants - Administration & Dosage
(1)
Anticoagulants - Adverse Effects
(1)
Anticoagulants - Therapeutic Use
(1)
Anticoagulants, Oral
(1)
Anticoagulation
(1)
Antifibrinolytic Agents - Therapeutic Use
(1)
Atrial Fibrillation
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Letter to the Editor “Gender related aspects of bleeding with rivaroxaban in venous thromboembolism — Potential for pitfalls”

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE

Thromboembolische Komplikationen bei COVID-19

Blutungskomplikationen unter oraler Antikoagulation

Neue orale Antikoagulanzien und Endoskopie – was ist zu beachten?

Blutgerinnung und hormonelle Kontrazeptiva: Was muss man bei der Verordnung beachten?

Abstract 18238: Transition from Vitamin-K-antagonists to New Oral Anticoagulants in Daily Care - First Results of the Prospective NOAC Registry (NCT 01588119)

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

A REAL-WORD, PROSPECTIVE OBSERVATIONAL STUDY TO COMPARE RIVAROXABAN VERSUS VITAMIN K ANTAGONIST TREATMENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE

Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis

Abstract 13927: Advanced Age and Preferential Use of Vitamin K Antagonists in Severe Renal Impairment: First Results of the XARENO Registry in Patients With Non-valvular Atrial Fibrillation and Non-dialysis Dependent Advanced Chronic Kidney Disease

ANDEXANET ALFA FOR ACUTE BLEEDING DURING TREATMENT WITH ENOXAPARIN

Hormonal Contraception. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry Number 015/015, January 2020)

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses

59: ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY

Abstract T MP57: Are The Recommendations For The Emergency Management Of Acute Ischemic Stroke Patients On Novel Oral Anticoagulants Sufficient?

The CHA 2 DS 2 -VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

Stroke prevention in atrial fibrillation: evidence from real-life studies: Table 1

Continued commitment to safety: building on the existing rivaroxaban knowledge base: Table 1

Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059)

Abstract 13021: Comparative Risk of Major Bleeding With Rivaroxaban and Warfarin: Population Based Cohort Study of Unprovoked Venous Thromboembolism

Aktive Filter

Suchergebnisse filtern